JP2025511705A5 - - Google Patents
Info
- Publication number
- JP2025511705A5 JP2025511705A5 JP2024559131A JP2024559131A JP2025511705A5 JP 2025511705 A5 JP2025511705 A5 JP 2025511705A5 JP 2024559131 A JP2024559131 A JP 2024559131A JP 2024559131 A JP2024559131 A JP 2024559131A JP 2025511705 A5 JP2025511705 A5 JP 2025511705A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- sequence
- conjugate according
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2022-0043049 | 2022-04-06 | ||
| KR20220043049 | 2022-04-06 | ||
| PCT/IB2023/000193 WO2023194800A1 (en) | 2022-04-06 | 2023-04-05 | Antibody-drug conjugate comprising antibody against human trop2 and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511705A JP2025511705A (ja) | 2025-04-16 |
| JP2025511705A5 true JP2025511705A5 (https=) | 2026-04-13 |
Family
ID=88244156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559131A Pending JP2025511705A (ja) | 2022-04-06 | 2023-04-05 | ヒトｔｒｏｐ２に対する抗体を含む抗体－薬物コンジュゲート及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250242043A1 (https=) |
| EP (1) | EP4504272A1 (https=) |
| JP (1) | JP2025511705A (https=) |
| KR (1) | KR20250049520A (https=) |
| CN (2) | CN119584992A (https=) |
| AU (1) | AU2023249557A1 (https=) |
| CA (1) | CA3247616A1 (https=) |
| IL (1) | IL316044A (https=) |
| MX (1) | MX2024012319A (https=) |
| TW (1) | TW202500190A (https=) |
| WO (1) | WO2023194800A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025228298A1 (zh) * | 2024-04-28 | 2025-11-06 | 福佑泰生物制药公司 | 靶向TROP2xPD-L1的双特异性抗体药物偶联物及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014371934B2 (en) * | 2013-12-25 | 2020-01-23 | Daiichi Sankyo Company, Limited | Anti-TROP2 antibody-drug conjugate |
| EP3227340B1 (en) * | 2014-12-04 | 2020-06-17 | Mediterranea Theranostic S.R.L. | Humanized anti-trop-2 monoclonal antibodies and uses thereof |
| WO2022211508A1 (ko) * | 2021-03-30 | 2022-10-06 | 주식회사 레고켐바이오사이언스 | 인간 cldn18.2에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
-
2023
- 2023-04-05 WO PCT/IB2023/000193 patent/WO2023194800A1/en not_active Ceased
- 2023-04-05 AU AU2023249557A patent/AU2023249557A1/en active Pending
- 2023-04-05 CN CN202380043883.1A patent/CN119584992A/zh active Pending
- 2023-04-05 EP EP23784412.1A patent/EP4504272A1/en active Pending
- 2023-04-05 US US18/854,516 patent/US20250242043A1/en active Pending
- 2023-04-05 IL IL316044A patent/IL316044A/en unknown
- 2023-04-05 CA CA3247616A patent/CA3247616A1/en active Pending
- 2023-04-05 JP JP2024559131A patent/JP2025511705A/ja active Pending
- 2023-04-05 CN CN202510914913.2A patent/CN120733061A/zh active Pending
- 2023-04-05 KR KR1020247036601A patent/KR20250049520A/ko active Pending
- 2023-07-07 TW TW112125452A patent/TW202500190A/zh unknown
-
2024
- 2024-10-04 MX MX2024012319A patent/MX2024012319A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021063058A5 (https=) | ||
| EP4321180A1 (en) | Antibody-drug conjugate including antibody against human cldn18.2, and use thereof | |
| JP2021523232A5 (https=) | ||
| JP7536188B2 (ja) | エキサテカン誘導体及びそのリンカー－ペイロードとコンジュゲート | |
| JP2025510629A (ja) | カンプトテシンコンジュゲート | |
| JP2022522547A5 (https=) | ||
| JP7657153B2 (ja) | 切断可能なリンカーを含む化合物及びその使用 | |
| BG63492B1 (bg) | Методи за получаване на мономерни конюгати калихеамициново производно/носител | |
| JP6704900B2 (ja) | ポリオキサゾリン抗体薬物複合体 | |
| CN120076831A (zh) | 抗ror1抗体和抗体缀合物、包含抗ror1抗体或抗体缀合物的组合物、以及制备和使用抗ror1抗体和抗体缀合物的方法 | |
| JP7657152B2 (ja) | 切断可能なリンカーを含む化合物及びその使用 | |
| JP2026510495A (ja) | ヒトｌ１ｃａｍに対する抗体を含む抗体－薬物コンジュゲートおよびその使用 | |
| JP2025523117A (ja) | リンカー、コンジュゲート及びその用途 | |
| JP2022530482A (ja) | トリス構造を有するリンカーを含むリガンド―薬物複合体 | |
| JP2025511705A5 (https=) | ||
| EP3770170A1 (en) | Screening of fixed-point coupling sites of cysteine-modified antibody-toxin conjugate (tdc) | |
| JP2025511705A (ja) | ヒトｔｒｏｐ２に対する抗体を含む抗体－薬物コンジュゲート及びその使用 | |
| JP2026508115A (ja) | リンカー薬物、その抗体－薬物コンジュゲート、並びにそれらの調製方法及び使用 | |
| JP2022500454A (ja) | 抗葉酸受容体抗体コンジュゲートによる併用療法 | |
| HK40104908A (zh) | 一种包括针对人cldn18.2的抗体的抗体药物偶联物及其用途 | |
| TW202344271A (zh) | 包含針對人ｃｌｄｎ１８．２的抗體的抗體藥物偶聯物及其用途 | |
| RU2024133074A (ru) | Конъюгат антитело-лекарственное средство, содержащий антитело к trop2 человека, и его применение | |
| RU2025127084A (ru) | Конъюгат антитело-лекарственное средство, содержащий антитела против l1cam человека, и его применение | |
| HK40117773A (zh) | 包含抗人trop2的抗体的抗体-药物缀合物及其用途 | |
| RU2021128538A (ru) | Коньюгаты антитело-лекарственное средство, включающие антитело против человеческого dlk1, и их применение |